{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T20:24:07Z","timestamp":1750451047109},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.pnpbp.2006.11.003","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T07:25:57Z","timestamp":1166167557000},"page":"567-570","source":"Crossref","is-referenced-by-count":13,"title":["Possible levomepromazine\u2013clozapine interaction: Two case reports"],"prefix":"10.1016","volume":"31","author":[{"given":"Francesca","family":"Bugamelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mandrioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Kenndler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Boncompagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Augusta","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.11.003_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euroneuro.2003.09.001","article-title":"Plasma amisulpride levels in schizophrenia or schizoaffective disorder","volume":"14","author":"Bergermann","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2362.33.s2.3.x","article-title":"Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implications","volume":"33","author":"Cascorbi","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00442559","article-title":"Clozapine: neuroleptic-induced EPS and tardive dyskinesia","volume":"99","author":"Casey","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-199404000-00006","article-title":"Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients","volume":"14","author":"Centorrino","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00607681","article-title":"Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup","volume":"11","author":"Dahl","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/PL00005298","article-title":"Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine","volume":"358","author":"Fang","year":"1998","journal-title":"N\u2013S Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.11.003_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0773.1994.tb00357.x","article-title":"Effect of levomepromazine and metabolites on debrisoquine hydroxylation in the rat","volume":"75","author":"Hals","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00004714-199312000-00003","article-title":"Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking","volume":"13","author":"Hasegawa","year":"1993","journal-title":"Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/npp.1994.34","article-title":"Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis","volume":"11","author":"Hasegawa","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00429215","article-title":"Clozapine: plasma levels and prolactin response","volume":"73","author":"Kane","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0447.1993.tb03391.x","article-title":"Levomepromazine receptor binding profile in human brain \u2014 implications for treatment resistant schizophrenia","volume":"87","author":"Lal","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib12","first-page":"271","article-title":"Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial","volume":"31","author":"Lal","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/ajp.149.1.68","article-title":"Clozapine-induced weight gain: prevalence and clinical relevance","volume":"149","author":"Leadbetter","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00007691-199011000-00011","article-title":"High-performance liquid chromatographic determination of levomepromazine and its main metabolites in serum and urine","volume":"12","author":"Loennechen","year":"1990","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib15","unstructured":"Mercolini L, Bugamelli F, Kenndler E, Boncompagni G, Franchini L, Raggi MA. Simultaneous determination of the antipsychotic drugs levomeproazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction. J Chromatogr B in press. ____________________________doi:10.1016\/j.jchromb.2006.09.019 (Available on line http:\/\/www.sciencedirect.com\/science\/article\/B6X0P-4M3J0X6-1\/2\/3100b824417b13cfb88bb5722965296c)."},{"key":"10.1016\/j.pnpbp.2006.11.003_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/00912700122010717","article-title":"Contributions of five human cytochrome P450 isoforms to the N-emethylation of clozapine in vitro at low and high concentrations","volume":"41","author":"Olesen","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02246112","article-title":"Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study","volume":"117","author":"Olesen","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib18","first-page":"231","article-title":"Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients","volume":"148","author":"Perry","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.11.003_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0924-977X(98)00040-6","article-title":"Drug metabolism and atypical antipsychotics","volume":"9","author":"Prior","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2174\/0929867023369826","article-title":"Therapeutic drug monitoring: chemical\u2013clinical correlations of atypical antipsychotic drugs","volume":"9","author":"Raggi","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02466779","article-title":"Determination of clozapine in human plasma by solid-phase extraction and liquid chromatography with amperometric detection","volume":"47","author":"Raggi","year":"1998","journal-title":"Chromatographia"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02467191","article-title":"Development and validation of an HPLC method for the simultaneous determination of clozapine and desmethylclozapine in plasma of schizophrenic patients","volume":"49","author":"Raggi","year":"1999","journal-title":"Chromatographia"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02490556","article-title":"An improved HPLC-ED method for monitoring plasma levels of clozapine and its active metabolites in schizophrenic patients","volume":"51","author":"Raggi","year":"2000","journal-title":"Chromatographia"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib24","first-page":"84","article-title":"Pharmacogenetics and existing therapies","volume":"17","author":"R\u00e4go","year":"2003","journal-title":"WHO Drug Inf"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4088\/JCP.v60n0701","article-title":"Antipsychotic polypharmacy, part 1: therapeutic option or dirty little secret?","volume":"60","author":"Stahl","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib26","series-title":"Psychopharmacology of antipsychotics","author":"Stahl","year":"1999"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.11.003_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.ps.54.1.55","article-title":"Combination antipsychotic therapy in clinical practice","volume":"54","author":"Tapp","year":"2003","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1176\/ajp.152.9.1401b","article-title":"Pharmacokinetic interaction between risperidone and clozapine","volume":"152","author":"Tyson","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.11.003_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00023210-199504050-00006","article-title":"Clozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents","volume":"4","author":"Wagstaff","year":"1995","journal-title":"CNS Drugs"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2006.11.003_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci Int"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T15:25:54Z","timestamp":1547133954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606003988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0278584606003988"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.11.003","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}